PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond

被引：38

作者：

Banerjee, Susana ^{[2
]}

Kaye, Stan ^{[1
]}

机构：

[1] Royal Marsden NHS Fdn Trust, Div Clin Studies, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England

[2] Royal Marsden NHS Fdn Trust, Gynaecol Unit, Sutton SM2 5PT, Surrey, England

来源：

CURRENT ONCOLOGY REPORTS | 2011年 / 13卷 / 06期

关键词：

PARP inhibitors; Ovarian cancer; BRCA; Olaparib; Endometrial; POLY(ADP-RIBOSE) POLYMERASE INHIBITOR; MUTANT-CELLS; TUMOR; MUTATIONS; CARCINOMA; FEATURES; DELETION; REPAIR;

D O I：

10.1007/s11912-011-0193-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Poly(ADP-ribose)polymerase (PARP) inhibitors are showing considerable promise for the treatment of BRCA mutation-associated ovarian and breast cancer. This approach exploits a synthetic lethal strategy to target the specific DNA repair pathway in cancers that harbor mutations in the BRCA1 or BRCA2 genes. Accumulating evidence suggests that PARP inhibitors may have a wider application in the treatment of sporadic, high-grade serous ovarian cancers and other cancers including endometrial cancer. In this review, we discuss the clinical development of PARP inhibitors in ovarian cancer and explore challenges that need to be addressed if the full potential of these agents is to be realized.

引用

页码：442 / 449

页数：8

共 50 条

[21] PARP INHIBITORS IN OVARIAN CANCER THERAPY [J].

Pisula, Agata ;

Sienicka, Agnieszka ;

Dobrowolska-Redo, Agnieszka ;

Kacperczyk-Bartnik, Joanna ;

Romejko-Wolniewicz, Ewa .

PROSPECTS IN PHARMACEUTICAL SCIENCES, 2024, 22 (02) :71-74

[22] PARP Inhibitors for the Treatment of Ovarian Cancer [J].

Cortesi, Laura ;

Toss, Angela ;

Cucinotto, Iole .

CURRENT CANCER DRUG TARGETS, 2018, 18 (09) :877-893

[23] PARP inhibitors in the ovarian cancer therapy [J].

Kruczala, Maksymilian A. ;

Grela-Wojewoda, Aleksandra ;

Cedrych, Ida .

GINEKOLOGIA POLSKA, 2016, 87 (02) :131-134

[24] PARP inhibitors in the treatment of ovarian cancer [J].

Zeimet, Alain G. ;

Wieser, Verena ;

Knoll, Katharina ;

Reimer, Daniel ;

Marth, Christian .

MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (02) :198-201

[25] Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes [J].

Hodgson, Darren R. ;

Dougherty, Brian A. ;

Lai, Zhongwu ;

Fielding, Anitra ;

Grinsted, Lynda ;

Spencer, Stuart ;

O'Connor, Mark J. ;

Ho, Tony W. ;

Robertson, Jane D. ;

Lanchbury, Jerry S. ;

Timms, Kirsten M. ;

Gutin, Alexander ;

Orr, Maria ;

Jones, Helen ;

Gilks, Blake ;

Womack, Chris ;

Gourley, Charlie ;

Ledermann, Jonathan ;

Barrett, J. Carl .

BRITISH JOURNAL OF CANCER, 2018, 119 (11) :1401-1409

[26] PARP inhibitor treatment of advanced breast cancer beyond the BRCA-mutated type: a meta-analysis [J].

Yan, Feifei ;

Jiang, Qi ;

He, Mengye ;

Shen, Peng .

FUTURE ONCOLOGY, 2021, 17 (18) :2381-2393

[27] PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer [J].

Rose, Peter G. ;

Yao, Meng ;

Chambers, Laura M. ;

Mahdi, Haider ;

DeBernardo, Robert ;

Michener, Chad M. ;

AlHilli, Miriam ;

Ricci, Stephanie ;

Vargas, Roberto .

ANTI-CANCER DRUGS, 2021, 32 (10) :1086-1092

[28] MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer [J].

Bustos, Matias A. ;

Yokoe, Takamichi ;

Shoji, Yoshiaki ;

Kobayashi, Yuta ;

Mizuno, Shodai ;

Murakami, Tomohiro ;

Zhang, Xiaoqing ;

Sekhar, Sreeja C. ;

Kim, Soomin ;

Ryu, Suyeon ;

Knarr, Matthew ;

Vasilev, Steven A. ;

Difeo, Analisa ;

Drapkin, Ronny ;

Hoon, Dave S. B. .

CELL AND BIOSCIENCE, 2023, 13 (01)

[29] PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations [J].

Vanacker, Helene ;

Harter, Philipp ;

Labidi-Galy, Sana Intidhar ;

Banerjee, Susana ;

Oaknin, Ana ;

Lorusso, Domenica ;

Ray-Coquard, Isabelle .

CANCER TREATMENT REVIEWS, 2021, 99

[30] PARP Inhibitors in Epithelial Ovarian Cancer: State of Art and Perspectives of Clinical Research [J].

Gadducci, Angiolo ;

Guerrieri, Maria Elena .

ANTICANCER RESEARCH, 2016, 36 (05) :2055-2064

← 1 2 3 4 5 →